4Conlon JM, Yano K, Waugh D, et al. Distribution and molecular forms of urotensin Ⅱ and its role in cardiovascular regulation in vertebrates. J Exp Zool,1996,275:226-238.
5Coulouarn Y, Lihrmann I, Jegou S, et al. Cloning of cDNA encoding the urotensin Ⅱ precusor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord . Proc Natl Acad Sci USA , 1998,95:15803-15808.
6Ames RS,Sarau HM,Chambers JK,et al. Human urotensin Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPR14 .Nature, 1999,401:282-286.
7Gartlon J, Parker F, Harrison DC, et al . Central effects of urotensin Ⅱ following ICV administration in rats. Psychopharmacology (Berl),2001,155:426-433.
8Maguire JJ, Kuc RE, Davenport AP. Orphan-receptor ligand human urotensin Ⅱ : receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin 1. Br J Pharmacol, 2000,131:441-446.
9Stirrat A, Gallagher M, Douglas SA, et al. Potent vasodilator responses to human urotensin- Ⅱ in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Circ Physiol, 2001,280 : H925-928.
10Bohm F, Pernow J . Urotensin Ⅱ evokes potent vasoconstriction in humans in vivo. Br J Pharmacol,2002,135:25-27.
7Maguire JJ, Kue RE, Wiley KE, et al. Cellular distribution of immunoreactive urotensin-Ⅱ in human tissues with evidence of increased expression in atheroselerosis and a greater constrictor response of small compared to large coronary arteries. Peptides, 2004,25 : 1767-1774.
8Stirrat A, Gallagher M, Douglas SA, et al. Potent vasodilator responses to human urotensin-Ⅱ in human pulmonary and abdominal resistance arteries. Am J Physiol Heart Cire Physiol, 2001, 280:925-928.
9Watanabe T, Pakala R, Katagiri T, et al. Synergistic effect of urotensin Ⅱ with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation, 2001, 104:16-18.
10Belun DJ, Herald CL, Oh]stein EH, et al. Pharmacological characterization of SB-710411 ( Cpa-c [ D-Cys-Pal-D-Trp-Lys-Val- Cys ]-Cpa-amide ), a novel peptidic umtensin-Ⅱ receptor antagonist. Br J Pharmacol, 2002 ,137:449-458.
